A new multimodal stool nucleic acid (mm-sNA) test, ColoAlert by Mainz Biomed, has shown remarkable sensitivity and specificity in detecting…
Browsing: Clinical Updates
Exact Sciences has released promising results from its trial of the Oncodetect test, designed to identify molecular residual disease (MRD)…
A recent analysis from the University of Pittsburgh Medical Center highlights that nearly half of patients prescribed multitarget stool DNA…
Guardant Health has announced that its Guardant Reveal test, a blood-based assay for minimal residual disease (MRD) detection, is now…
Oshi Health has released its 2024 Impact Report, showcasing the transformative impact of its virtual, multidisciplinary GI care model on…
The rising cost of colonoscopies and restrictive U.S. insurance policies are deterring young adults from timely colorectal cancer (CRC) testing,…
The Lancet Diabetes & Endocrinology recently published a proposal by 58 global experts advocating for a significant overhaul of how…
A new study published in JAMA Network Open cautions that prioritizing blood-based colorectal cancer (CRC) screening tests over stool-based tests…
AGA’s latest clinical practice update outlines what to do with nonampullary duodenal lesions. These polyps are found in up to…
In 2024, major drug approvals in gastroenterology and hepatology included FDA and EMA authorizations of biosimilars to Stelara and Humira…